...
机译:Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative study.
Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy.;
Acromegaly; Adenoma; Antineoplastic Agents; Hormonal; Octreotide; Pituitary Neoplasms; 肢端肥大症; 腺瘤; 抗肿瘤药; 激素; 奥曲肽; 垂体肿瘤;